Memantine reduces consumption of highly palatable food in a rat model of binge eating

Amino Acids

Volumn 40, Issue 2, 2011, Pages 477-485

  Popik, Piotr ^a   Kos, Tomasz ^a   Zhang, Yulei ^b   Bisaga, Adam ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Binge eating; Compulsive behavior; Generalized estimating equations; Memantine; mGluR5 antagonist; Sibutramine

Indexed keywords

3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE EATING DISORDER; BODY WEIGHT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT CHANGE;

ANIMALS; BINGE-EATING DISORDER; DIETARY FATS; DISEASE MODELS, ANIMAL; EATING; FEEDING BEHAVIOR; HUMANS; MALE; MEMANTINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE;

RATTUS;

EID: 78751573017     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0659-3     Document Type: Article

References (44)

1. DE Arterburn PK Crane DL Veenstra 2004 The efficacy and safety of sibutramine for weight loss: a systematic review Arch Intern Med 164 994 1003 1:CAS:528:DC%2BD2cXkvVegsb4%3D 10.1001/archinte.164.9.994 15136309 (Pubitemid 38581520)
2. NM Avena P Rada BG Hoebel 2009 Sugar and fat bingeing have notable differences in addictive-like behavior J Nutr 139 623 628 1:CAS:528: DC%2BD1MXjsFKiu7k%3D 10.3945/jn.108.097584 19176748
3. HR Berthoud 2004 Neural control of appetite: cross-talk between homeostatic and non-homeostatic systems Appetite 43 315 317 10.1016/j.appet. 2004.04.009 15527935 (Pubitemid 39440999)
4. A Bisaga P Popik 2000 In search of a new pharmacological treatment of drug addiction: N-methyl-d-aspartate (NMDA) antagonists Drug Alcohol Depend 59 1 15 1:CAS:528:DC%2BD3cXhsFGlu7o%3D 10.1016/S0376-8716(99)00107-6 10706971
5. A Bisaga W Danysz RW Foltin 2008 Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder Eur Neuropsychopharmacol 18 794 802 1:CAS:528:DC%2BD1cXhtFOlu7bM 10.1016/j.euroneuro.2008.05.004 18573641
6. JE Blundell G Finlayson 2004 Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption? Physiol Behav 82 21 25 1:CAS:528:DC%2BD2cXlsVWjtbY%3D 10.1016/j.physbeh.2004.04. 021 15234585 (Pubitemid 38968503)
7. MM Boggiano JR Dorsey JM Thomas DL Murdaugh 2009 The Pavlovian power of palatable food: lessons for weight-loss adherence from a new rodent model of cue-induced overeating Int J Obes (Lond) 33 693 701 1:STN:280: DC%2BD1MvhvFGluw%3D%3D 10.1038/ijo.2009.57
8. MJ Bradbury U Campbell D Giracello D Chapman CD King L Tehrani ND Cosford J Anderson MA Varney AM Strack 2005 Metabotropic glutamate receptor, mGlu5, is a mediator of appetite and energy balance in rats and mice J Pharmacol Exp Ther 313 395 402 1:CAS:528:DC%2BD2MXjtlSntrc%3D 10.1124/jpet.104.076406 15590770 (Pubitemid 40411366)
9. BP Brennan JL Roberts KV Fogarty KA Reynolds JM Jonas JI Hudson 2008 Memantine in the treatment of binge eating disorder: an open-label, prospective trial Int J Eat Disord 41 520 526 10.1002/eat.20541 18433015
10. A Buda-Levin FH Wojnicki RL Corwin 2005 Baclofen reduces fat intake under binge-type conditions Physiol Behav 86 176 184 1:CAS:528:DC%2BD2MXhtVWnsbrK 10.1016/j.physbeh.2005.07.020 16140347 (Pubitemid 41316622)
11. C Chiamulera MP Epping-Jordan A Zocchi C Marcon C Cottiny S Tacconi M Corsi F Orzi F Conquet 2001 Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice Nat Neurosci 4 873 874 1:CAS:528:DC%2BD3MXmtlaqurc%3D 10.1038/nn0901-873 11528416 (Pubitemid 32801588)
12. C Cifani C Polidori S Melotto R Ciccocioppo M Massi 2009 A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam Psychopharmacology (Berl) 204 113 125 1:CAS:528:DC%2BD1MXhtlSqug%3D%3D 10.1007/s00213-008-1442-y
13. C Colantuoni J Schwenker J McCarthy P Rada B Ladenheim JL Cadet GJ Schwartz TH Moran BG Hoebel 2001 Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain NeuroReport 12 3549 3552 1:CAS:528:DC%2BD3MXptVOktbg%3D 10.1097/00001756-200111160-00035 11733709
14. RL Corwin A Buda-Levin 2004 Behavioral models of binge-type eating Physiol Behav 82 123 130 1:CAS:528:DC%2BD2cXlsVWis74%3D 10.1016/j.physbeh.2004. 04.036 15234600 (Pubitemid 38968518)
15. RL Corwin FH Wojnicki JO Fisher SG Dimitriou HB Rice MA Young 1998 Limited access to a dietary fat option affects ingestive behavior but not body composition in male rats Physiol Behav 65 545 553 1:CAS:528:DyaK1MXhtFelsg%3D%3D 10.1016/S0031-9384(98)00201-7 9877422 (Pubitemid 29015772)
16. MJ Devlin SZ Yanovski GT Wilson 2000 Obesity: what mental health professionals need to know Am J Psychiatry 157 854 866 1:STN:280: DC%2BD3c3pt1OgsQ%3D%3D 10.1176/appi.ajp.157.6.854 10831462 (Pubitemid 30412334)
17. MJ Devlin JA Goldfein I Dobrow 2003 What is this thing called BED? Current status of binge eating disorder nosology Int J Eat Disord 34 Suppl S2 S18 10.1002/eat.10201 12900982 (Pubitemid 36935709)
18. C Erlanson-Albertsson 2005 How palatable food disrupts appetite regulation Basic Clin Pharmacol Toxicol 97 61 73 1:CAS:528:DC%2BD2MXntVSmtrs%3D 10.1111/j.1742-7843.2005.pto-179.x 15998351 (Pubitemid 41021104)
19. CG Fairburn Z Cooper HA Doll P Norman M O'Connor 2000 The natural course of bulimia nervosa and binge eating disorder in young women Arch Gen Psychiatry 57 659 665 1:STN:280:DC%2BD3czlt1yksA%3D%3D 10.1001/archpsyc.57.7.659 10891036
20. RW Foltin W Danysz A Bisaga 2008 A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine Psychopharmacology (Berl) 199 583 592 1:CAS:528: DC%2BD1cXptVCisb8%3D 10.1007/s00213-008-1178-8
21. JT Gass MF Olive 2008 Glutamatergic substrates of drug addiction and alcoholism Biochem Pharmacol 75 218 265 1:CAS:528:DC%2BD2sXhsVCksLjL 10.1016/j.bcp.2007.06.039 17706608 (Pubitemid 350235390)
22. MM Hagan PC Chandler PK Wauford RJ Rybak KD Oswald 2003 The role of palatable food and hunger as trigger factors in an animal model of stress induced binge eating Int J Eat Disord 34 183 197 10.1002/eat.10168 12898554 (Pubitemid 36935720)
23. Herman BH, Frankenheim J, Litten RZ, Sheridan PH, Weight FF, Zukin SR (2003) Glutamate and addiction. Humana Press, Totowa
24. M Hermanussen JA Tresguerres 2005 A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders Econ Hum Biol 3 329 337 1:STN:280:DC%2BD2MzmvFGmuw%3D%3D 10.1016/j.ehb.2005.04.001 15886075 (Pubitemid 40984134)
25. HC Jackson AM Needham LJ Hutchins SE Mazurkiewicz DJ Heal 1997 Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat Br J Pharmacol 121 1758 1762 1:CAS:528:DyaK2sXlslaqtbw%3D 10.1038/sj.bjp.0701312 9283714 (Pubitemid 27343407)
26. WP James A Astrup N Finer J Hilsted P Kopelman S Rossner WH Saris LF Van Gaal 2000 Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance Lancet 356 2119 2125 1:CAS:528:DC%2BD3MXitlGhtQ%3D%3D 10.1016/S0140-6736(00)03491-7 11191537 (Pubitemid 32047947)
27. E Koros H Rosenbrock G Birk C Weiss F Sams-Dodd 2007 The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats Neuropsychopharmacology 32 562 576 1:CAS:528: DC%2BD2sXhslWhu7s%3D 10.1038/sj.npp.1301133 16794564
28. JH Lee TA Herzog CD Meade MS Webb TH Brandon 2007 The use of GEE for analyzing longitudinal binomial data: a primer using data from a tobacco intervention Addict Behav 32 187 193 10.1016/j.addbeh.2006.03.030 16650625 (Pubitemid 44708494)
29. McShane R, Areosa Sastre A, Minakaran N (2006) Memantine for dementia. Cochrane Database Syst Rev CD003154
30. JE Mitchell BA Gosnell JL Roerig M de Zwaan SA Wonderlich RD Crosby MA Burgard BN Wambach 2003 Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm Obes Res 11 599 602 1:CAS:528:DC%2BD3sXksVOgtrY%3D 10.1038/oby.2003.85 12740447
31. P Popik M Wrobel R Rygula A Bisaga AY Bespalov 2003 Effects of memantine, an NMDA receptor antagonist on place preference conditioned with drug and non-drug reinforcers in mice Behav Pharmacol 14 237 244 1:CAS:528: DC%2BD3sXks1yqtrY%3D 12799526
32. P Popik M Wrobel A Bisaga 2006 Reinstatement of morphine conditioned reward is blocked by memantine Neuropsychopharmacology 31 160 170 1:CAS:528:DC%2BD2MXhtlWjsrzO 15886718
33. G Rammes W Danysz CG Parsons 2008 Pharmacodynamics of memantine: an update Curr Neuropharmacol 6 55 78 1:CAS:528:DC%2BD1cXlslehurY%3D 10.2174/157015908783769671 19305788 (Pubitemid 351513473)
34. CB Saper TC Chou JK Elmquist 2002 The need to feed: homeostatic and hedonic control of eating Neuron 36 199 211 1:CAS:528:DC%2BD38XotlansL8%3D 10.1016/S0896-6273(02)00969-8 12383777 (Pubitemid 35217887)
35. M Tanofsky-Kraff ML Cohen SZ Yanovski C Cox KR Theim M Keil JC Reynolds JA Yanovski 2006 A prospective study of psychological predictors of body fat gain among children at high risk for adult obesity Pediatrics 117 1203 1209 10.1542/peds.2005-1329 16585316 (Pubitemid 46071513)
36. LR Vartanian MB Schwartz KD Brownell 2007 Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis Am J Public Health 97 667 675 10.2105/AJPH.2005.083782 17329656 (Pubitemid 47280164)
37. BT Walsh MJ Devlin 1998 Eating disorders: progress and problems Science 280 1387 1390 1:CAS:528:DyaK1cXjtlantbc%3D 10.1126/science.280.5368.1387 9603723 (Pubitemid 28264821)
38. TE Weltzin LK Hsu C Pollice WH Kaye 1991 Feeding patterns in bulimia nervosa Biol Psychiatry 30 1093 1110 1:STN:280:DyaK387jsFaksA%3D%3D 10.1016/0006-3223(91)90180-T 1777527
39. DE Wilfley SJ Crow JI Hudson JE Mitchell RI Berkowitz V Blakesley BT Walsh 2008 Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study Am J Psychiatry 165 51 58 10.1176/appi.ajp.2007.06121970 18056225 (Pubitemid 351704552)
40. FH Wojnicki G Charny RL Corwin 2008 Binge-type behavior in rats consuming trans-fat-free shortening Physiol Behav 94 627 629 1:CAS:528: DC%2BD1cXmsFykurY%3D 10.1016/j.physbeh.2008.03.016 18499201 (Pubitemid 351834749)
41. FH Wojnicki DS Johnson RL Corwin 2008 Access conditions affect binge-type shortening consumption in rats Physiol Behav 95 649 657 1:CAS:528: DC%2BD1cXhsVWls7fJ 10.1016/j.physbeh.2008.09.017 18851983
42. KJ Wong FH Wojnicki RL Corwin 2009 Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions Pharmacol Biochem Behav 92 528 536 1:CAS:528:DC%2BD1MXjsFWrtrg%3D 10.1016/j.pbb.2009.02.002 19217918
43. SZ Yanovski 2003 Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic? Int J Eat Disord 34 Suppl S117 S120 10.1002/eat.10211 12900992 (Pubitemid 36935719)
44. SL Zeger KY Liang 1986 Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 121 130 1:STN:280:DyaL283ktlGmuw%3D%3D 10.2307/2531248 3719049